Chen Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chen Yang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Guang-Yan Cai
First Medical Center of Chinese PLA General Hospital Department of Nephrology Beijing
2 shared publicationsZhe Feng
First Medical Center of Chinese PLA General Hospital Department of Nephrology Beijing
2 shared publicationsJie Wu
First Medical Center of Chinese PLA General Hospital Department of Nephrology Beijing
1 shared publicationPu Chen
First Medical Center of Chinese PLA General Hospital Department of Nephrology Beijing
1 shared publicationShu-Wei Duan
First Medical Center of Chinese PLA General Hospital Department of Nephrology Beijing
1 shared publicationShuang Liang
First Medical Center of Chinese PLA General Hospital Department of Nephrology Beijing
1 shared publication
Latest Publications
- 2 February 2026
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
Single-nephron eGFR and kidney function decline in IgA nephropathy
Background: During the progression of immunoglobulin A nephropathy (IgAN), residual nephrons compensate for nephron loss by increasing single-nephron estimated glomerular filtration rate (eGFR). This adaptive hyperfiltration may accelerate the decline in kidney function. However, due to measurement challenges, the prognostic value of single-nephron eGFR remains unclear. This study investigates its impact on kidney function decline in patients with IgAN. Methods: This observational cohort study included 187 biopsy-confirmed IgAN patients who had undergone computed tomography and biopsy during their hospitalization. Single-nephron eGFR was estimated by dividing total eGFR by nephron number, the latter of which was derived from the cortical volume and glomerular density. The primary composite outcome was kidney function decline, defined as a sustained annual eGFR decrease of ≥5 mL/min/1.73 m2, a ≥40% reduction in eGFR from baseline or end-stage renal disease. Cox proportional hazards models were fit to estimate associations between single-nephron eGFR and kidney function decline. Results: Among the 187 participants (45% women, mean age 38 ± 11 years), 57 experienced a decline in kidney function over a median follow-up period of 3.1 years. Participants were divided into three groups based on their single-nephron eGFR. Kaplan–Meier analysis demonstrated significantly reduced kidney survival in the high single-nephron eGFR group compared with the low and middle groups (log-rank P < .001). Compared with the low single-nephron eGFR group, multivariable hazard ratios for kidney function decline were 2.50 (95% confidence interval 1.10–5.67; P = .03) for the middle group and 5.30 (2.44–11.54; P < .001) for the high group. Conclusions: A higher single-nephron eGFR is identified as a risk factor for kidney function decline in patients with IgAN, which supports its potential as an early risk-stratification tool. Moreover, using eGFR cutoffs alone to define hyperfiltration may lead to misclassification due to its inability to distinguish patients with hyperfiltration from those without.
- 2 February 2026
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
Single-nephron eGFR and kidney function decline in IgA nephropathy
Background: During the progression of immunoglobulin A nephropathy (IgAN), residual nephrons compensate for nephron loss by increasing single-nephron estimated glomerular filtration rate (eGFR). This adaptive hyperfiltration may accelerate the decline in kidney function. However, due to measurement challenges, the prognostic value of single-nephron eGFR remains unclear. This study investigates its impact on kidney function decline in patients with IgAN. Methods: This observational cohort study included 187 biopsy-confirmed IgAN patients who had undergone computed tomography and biopsy during their hospitalization. Single-nephron eGFR was estimated by dividing total eGFR by nephron number, the latter of which was derived from the cortical volume and glomerular density. The primary composite outcome was kidney function decline, defined as a sustained annual eGFR decrease of ≥5 mL/min/1.73 m2, a ≥40% reduction in eGFR from baseline or end-stage renal disease. Cox proportional hazards models were fit to estimate associations between single-nephron eGFR and kidney function decline. Results: Among the 187 participants (45% women, mean age 38 ± 11 years), 57 experienced a decline in kidney function over a median follow-up period of 3.1 years. Participants were divided into three groups based on their single-nephron eGFR. Kaplan–Meier analysis demonstrated significantly reduced kidney survival in the high single-nephron eGFR group compared with the low and middle groups (log-rank P < .001). Compared with the low single-nephron eGFR group, multivariable hazard ratios for kidney function decline were 2.50 (95% confidence interval 1.10–5.67; P = .03) for the middle group and 5.30 (2.44–11.54; P < .001) for the high group. Conclusions: A higher single-nephron eGFR is identified as a risk factor for kidney function decline in patients with IgAN, which supports its potential as an early risk-stratification tool. Moreover, using eGFR cutoffs alone to define hyperfiltration may lead to misclassification due to its inability to distinguish patients with hyperfiltration from those without.
- Open Access
- 11 June 2021
- Published by KEAI Publishing in URINE
WITHDRAWN: The Potential of Spot and Overnight Urine in the Evaluating of Proteinuria and Electrolyte
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal
- 11 June 2021
- Published by KEAI Publishing in URINE
Open AccessWITHDRAWN: The Potential of Spot and Overnight Urine in the Evaluating of Proteinuria and Electrolyte
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal